Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0313
Full Text
Open PDFAbstract
Available in full text
Date
September 9, 2016
Authors
Publisher
American Association for Cancer Research (AACR)